\-\ Texto\\:\\ \ \(0\)\
\-\ rheumatoid\\ factor\\ positive\\ titer\\ 1\\:40\ \(0\)\
\-\ esr\\ 25\ \(1\)\
\-\ c\\-reactive\\ protein\\ 75\ \(0\)\
\-\ ana\\ negative\ \(0\)\
\-\ hla\\ b27\\ negative\ \(0\)\
\-\ rpr\\ non\\ reactive\ \(0\)\
\-\ treated\\ with\\ enbrel\\ for\\ arthritis\\.\ \(0\)\
\-\ there\\ are\\ multiple\\ small\\ ovoid\\ soft\\ tissue\\ densities\\ scattered\\ throughout\\ the\\ lungs\\ diffusely\\ and\\ bilaterally\\.\ \(0\)\
\-\ rheumatoid\\ arthritis\\ and\\ rheumatoid\\ lund\\ nodules\ \(0\)\
\-\ rheumatoid\\ nodules\ \(0\)\
\-\ granulomatous\\ disease\ \(29\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ 52\\ yo\\ man\\ with\\ rheumatoid\\ arthritis\\,\\ but\\ without\\ pulmonary\\ complaints\\ presents\\ for\\ \\"screening\\"\\ chest\\ x\\-ray\\ prior\\ to\\ starting\\ immune\\ modulation\\ therapy\\ \\(enbrel\\)\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ rheumatoid\\:\\ 0\\.5018874430049522\ \(0\)\
\-\ enbrel\\:\\ 0\\.34803722147752336\ \(0\)\
\-\ arthritis\\:\\ 0\\.2778561206265318\ \(0\)\
\-\ reactive\\:\\ 0\\.1954652125284571\ \(0\)\
\-\ modulation\\:\\ 0\\.18211291306558303\ \(0\)\
\-\ nodules\\:\\ 0\\.1809631746467483\ \(0\)\
\-\ lund\\:\\ 0\\.17401861073876168\ \(0\)\
\-\ b27\\:\\ 0\\.14998369459775224\ \(0\)\
\-\ titer\\:\\ 0\\.14808101692035733\ \(0\)\
\-\ hla\\:\\ 0\\.14188939227093086\ \(0\)\
\-\ negative\\:\\ 0\\.1410000144862123\ \(0\)\
\-\ rpr\\:\\ 0\\.14060100939564263\ \(0\)\
\-\ ana\\:\\ 0\\.13250670706882126\ \(0\)\
\-\ starting\\:\\ 0\\.1280520910476174\ \(0\)\
\-\ immune\\:\\ 0\\.12676370817232915\ \(0\)\
\-\ densities\\:\\ 0\\.11388481527268672\ \(0\)\
\-\ ovoid\\:\\ 0\\.11356020639933166\ \(0\)\
\-\ factor\\:\\ 0\\.10679726437204934\ \(0\)\
\-\ diffusely\\:\\ 0\\.10589989955300225\ \(0\)\
\-\ protein\\:\\ 0\\.1056817224539876\ \(0\)\
\-\ 52\\:\\ 0\\.10546590407251029\ \(0\)\
\-\ esr\\:\\ 0\\.10421780982008767\ \(0\)\
\-\ granulomatous\\:\\ 0\\.10122710643278372\ \(0\)\
\-\ 75\\:\\ 0\\.09988454983129434\ \(0\)\
\-\ scattered\\:\\ 0\\.09908910572570223\ \(0\)\
\-\ disease\\:\\ 0\\.09560240768155528\ \(0\)\
\-\ complaints\\:\\ 0\\.09377967385006039\ \(0\)\
\-\ screening\\:\\ 0\\.09250623893941977\ \(0\)\
\-\ lungs\\:\\ 0\\.08404155482216095\ \(0\)\
\-\ throughout\\:\\ 0\\.08375011890385277\ \(0\)\
\-\ 25\\:\\ 0\\.08067280798003829\ \(0\)\
\-\ bilaterally\\:\\ 0\\.0759472524953396\ \(0\)\
\-\ positive\\:\\ 0\\.07503859957542394\ \(0\)\
\-\ yo\\:\\ 0\\.07114342046960317\ \(0\)\
\-\ treated\\:\\ 0\\.07091395810583728\ \(0\)\
\-\ pulmonary\\:\\ 0\\.0694128235985753\ \(0\)\
\-\ for\\:\\ 0\\.06903003420983987\ \(0\)\
\-\ therapy\\:\\ 0\\.0654292907116985\ \(0\)\
\-\ prior\\:\\ 0\\.06371396136798206\ \(0\)\
\-\ metastatic\\:\\ 0\\.062455426002646\ \(0\)\
\-\ soft\\:\\ 0\\.06062529169230827\ \(0\)\
\-\ man\\:\\ 0\\.06028750011595105\ \(0\)\
\-\ chest\\:\\ 0\\.060109654789576535\ \(0\)\
\-\ without\\:\\ 0\\.06006543991911163\ \(0\)\
\-\ tissue\\:\\ 0\\.05973691348369354\ \(0\)\
\-\ small\\:\\ 0\\.05874120442990346\ \(0\)\
\-\ but\\:\\ 0\\.05631198307273203\ \(0\)\
\-\ multiple\\:\\ 0\\.05569935178513442\ \(0\)\
\-\ presents\\:\\ 0\\.05478035382101178\ \(0\)\
\-\ non\\:\\ 0\\.05403196525657827\ \(0\)\
\-\ and\\:\\ 0\\.047062265343695286\ \(0\)\
\-\ there\\:\\ 0\\.045311006061284076\ \(0\)\
\-\ with\\:\\ 0\\.04459678643135944\ \(0\)\
\-\ are\\:\\ 0\\.04321085743045319\ \(0\)\
\-\ to\\:\\ 0\\.0284688385601522\ \(0\)\
\-\ the\\:\\ 0\\.022722437941601226\ \(0\)\
